(Q33955283)

30 July 2017

1 reference

title

A review of the pharmacological and clinical profile of mirtazapine (English)

1 reference

30 July 2017

Anttila SA

1

1 reference

PubMed ID

11607047

30 July 2017

Leinonen EV

series ordinal

2

1 reference

30 July 2017

1 January 2001

1 reference

CNS Neuroscience & Therapeutics

30 July 2017

1 reference

30 July 2017

7

1 reference

30 July 2017

3

1 reference

30 July 2017

249-264

1 reference

Mirtazapine augmentation in the treatment of refractory depression.

30 July 2017

1 reference

12 December 2020

Mirtazepine causing hyperphagia

1 reference

12 December 2020

A pilot study of mirtazapine in post-traumatic stress disorder

1 reference

12 December 2020

Mirtazapine: a review of its use in major depression

1 reference

12 December 2020

Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression

1 reference

12 December 2020

Sexual functioning in depressed outpatients taking mirtazapine

1 reference

12 December 2020

Clinical experience with mirtazapine in the treatment of panic disorder

1 reference

12 December 2020

Mirtazapine versus selective serotonin reuptake inhibitors

1 reference

12 December 2020

Mirtazapine: other indications

1 reference

12 December 2020

Effects of mirtazapine on growth hormone, prolactin, and cortisol secretion in healthy male subjects

1 reference

12 December 2020

Mirtazapine in major depression with comorbid generalized anxiety disorder

1 reference

12 December 2020

Mirtazapine treats resting tremor, essential tremor, and levodopa-induced dyskinesias

1 reference

12 December 2020

Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. Nordic Antidepressant Study Group.

1 reference

12 December 2020

Lack of drug interactions between mirtazapine and risperidone in psychiatric patients: a pilot study

1 reference

12 December 2020

Mirtazapine: an inhibitor of cortisol secretion that does not influence growth hormone and prolactin secretion

1 reference

12 December 2020

Use of mirtazapine as prophylactic treatment for migraine headache

1 reference

12 December 2020

SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression

1 reference

12 December 2020

Mirtazapine for depression in patients with human immunodeficiency virus

1 reference

12 December 2020

Hypertensive urgency induced by an interaction of mirtazapine and clonidine

1 reference

12 December 2020

Clinical pharmacokinetics of mirtazapine

1 reference

12 December 2020

Pharmacokinetics of mirtazapine and lithium in healthy male subjects

1 reference

12 December 2020

Mirtazapine for the treatment of depression and nausea in breast and gynecological oncology.

1 reference

12 December 2020

Irritable bowel syndrome and mirtazapine

1 reference

12 December 2020

Weight gain and antidepressants

1 reference

12 December 2020

The role of mirtazapine in the pharmacotherapy of depression

1 reference

12 December 2020

Panic attacks during discontinuation of mirtazepine.

1 reference

12 December 2020

Metabolism of the antidepressant mirtazapine in vitro: contribution of cytochromes P-450 1A2, 2D6, and 3A4

1 reference

12 December 2020

Mirtazapine effects on alertness and sleep in patients as recorded by interactive telecommunication during treatment with different dosing regimens.

1 reference

12 December 2020

Economic impact of using mirtazapine compared to amitriptyline and fluoxetine in the treatment of moderate and severe depression in the UK

1 reference

12 December 2020

Concomitant use of mirtazapine and cimetidine: a drug-drug interaction study in healthy male subjects

1 reference

12 December 2020

Mirtazapine compared with paroxetine in major depression

1 reference

12 December 2020

Treatment of hot flushes with mirtazapine: four case reports

1 reference

12 December 2020

Pharmacokinetics and biotransformation of mirtazapine in human volunteers

1 reference

12 December 2020

The efficacy of selective serotonin re-uptake inhibitors in depression: a meta-analysis of studies against tricyclic antidepressants

1 reference

12 December 2020

A multicentre, double-blind, amitriptyline-controlled study of mirtazapine in patients with major depression

1 reference

12 December 2020

Mirtazapine vs. amitriptyline vs. placebo in the treatment of major depressive disorder

1 reference

12 December 2020

Mirtazapine : A Review of its Pharmacology and Therapeutic Potential in the Management of Major Depression

1 reference

12 December 2020

Actions and interactions of psychotropic drugs on human performance and mood: single doses of ORG 3770, amitriptyline, and diazepam.

1 reference

12 December 2020

A double-blind group comparative study using the new anti-depressant Org 3770, placebo and diazepam in patients with expected insomnia and anxiety before elective gynaecological surgery.

1 reference

12 December 2020

A double-blind placebo-controlled study of Org 3770 in depressed outpatients

1 reference

12 December 2020

A double-blind comparison of Org 3770, amitriptyline, and placebo in major depression

1 reference

12 December 2020

Mirtazapine is more effective than trazodone: a double-blind controlled study in hospitalized patients with major depression.

1 reference

12 December 2020

Double-blind study of mirtazapine and placebo in hospitalized patients with major depression

1 reference

12 December 2020

The pharmacologic profile of mirtazapine

1 reference

12 December 2020

A double-blind multicentre comparison of mirtazapine and amitriptyline in elderly depressed patients

1 reference

12 December 2020

A double-blind, fixed blood-level study comparing mirtazapine with imipramine in depressed in-patients

1 reference

12 December 2020

Clinical efficacy of mirtazapine: a review of meta-analyses of pooled data.

1 reference

12 December 2020

Safety of mirtazapine: a review

1 reference

12 December 2020

A double-blind study comparing the efficacy and tolerability of mirtazapine and doxepin in patients with major depression

1 reference

12 December 2020

Pharmacokinetics of mirtazapine from orally administered tablets: influence of a high-fat meal.

1 reference

12 December 2020

Meta-analysis of randomized, double-blind, placebo-controlled, efficacy and safety studies of mirtazapine versus amitriptyline in major depression

1 reference

12 December 2020

A risk-benefit assessment of mirtazapine in the treatment of depression

1 reference

12 December 2020

A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety.

1 reference

12 December 2020

Drug interactions--friend or foe?

1 reference

12 December 2020

Safety of mirtazapine in overdose

1 reference

12 December 2020

Mirtazapine withdrawal symptoms.

1 reference

12 December 2020

Mirtazapine versus amitriptyline in the long-term treatment of depression: a double-blind placebo-controlled study

1 reference

12 December 2020

Mirtazapine: efficacy and tolerability in comparison with fluoxetine in patients with moderate to severe major depressive disorder. Mirtazapine-Fluoxetine Study Group.

1 reference

12 December 2020

Hypomania associated with mirtazapine augmentation of sertraline

1 reference

12 December 2020

Hypertension during coprescription of mirtazapine and low-dose amitriptyline

1 reference

12 December 2020

Lack of sexual adverse effects with mirtazapine

1 reference

12 December 2020

Comparison of 2 treatment strategies for depressed inpatients: imipramine and lithium addition or mirtazapine and lithium addition

1 reference

12 December 2020

Identifiers

PubMed ID

11607047

1 reference

PubMed ID

11607047